Literature DB >> 24871442

New perspective on the natural course of chronic HBV infection.

Yong-Yuan Zhang1, Ke-Qin Hu, Zhongping Duan.   

Abstract

Chronic hepatitis B virus (HBV) infection is a significant threat to public health and an enormous burden on society. Mechanisms responsible for chronic HBV infection remain poorly understood. A better understanding of the natural course of chronic HBV infection may shed new light on the mechanisms underlying this disease and help in designing new antiviral strategies. Natural course of chronic HBV infection is conventionally viewed as an uninterrupted process that is usually marked by HBV e antigen (HBeAg) seroconversion or characterized by different phases associated with assumed host responses to HBV infection. However, none of these descriptions captures or highlights the core events that determine the natural course of chronic HBV infection. In this review, we briefly present the current knowledge on this subject and explain the significance and implication of events that occur during infection. A pre-core mutant becomes predominant in the viral population following elimination of the wild-type virus in duck hepatitis B virus-chronically infected animals. The coupled events in which first there is viral clearance that clears wild-type virus and then there is the reinfection of wild-type virus cleared livers with mutant virus are highly relevant to understanding of the natural course of chronic HBV infection under both treated and untreated conditions. In our new perspective, a general natural course of chronic HBV infection comprises cycles of viral clearance and reinfection, and such cycles prolong the chronic HBV infection course. Reviewing published data on the natural course of chronic HBV infection can reduce the possibility of missing important points in the initial data interpretation.

Entities:  

Mesh:

Year:  2014        PMID: 24871442     DOI: 10.1007/s11684-014-0339-x

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  71 in total

Review 1.  Hepatitis B therapy.

Authors:  Hellan Kwon; Anna S Lok
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-03-22       Impact factor: 46.802

Review 2.  Drug targets and molecular mechanisms of drug resistance in chronic hepatitis B.

Authors:  Marc Ghany; T Jake Liang
Journal:  Gastroenterology       Date:  2007-04       Impact factor: 22.682

3.  Properties of hepatitis B virus genome recovered from Vietnamese patients with fulminant hepatitis in comparison with those of acute hepatitis.

Authors:  R Yuasa; K Takahashi; B V Dien; N H Binh; T Morishita; K Sato; N Yamamoto; S Isomura; K Yoshioka; T Ishikawa; S Mishiro; S Kakumu
Journal:  J Med Virol       Date:  2000-05       Impact factor: 2.327

4.  Initial load of hepatitis B virus (HBV), its changing profile, and precore/core promoter mutations correlate with the severity and outcome of acute HBV infection.

Authors:  Shigehiko Sainokami; Koichi Abe; Akihiro Sato; Ryujin Endo; Yasuhiro Takikawa; Kazuyuki Suzuki; Hiroaki Okamoto
Journal:  J Gastroenterol       Date:  2007-03-30       Impact factor: 7.527

5.  Long-term use of entecavir in nucleoside-naïve Japanese patients with chronic hepatitis B infection.

Authors:  Osamu Yokosuka; Koichi Takaguchi; Shinichi Fujioka; Michiko Shindo; Kazuaki Chayama; Haruhiko Kobashi; Norio Hayashi; Chifumi Sato; Kendo Kiyosawa; Kyuichi Tanikawa; Hiroki Ishikawa; Nobuyuki Masaki; Taku Seriu; Masao Omata
Journal:  J Hepatol       Date:  2010-03-24       Impact factor: 25.083

6.  One-year entecavir or lamivudine therapy results in reduction of hepatitis B virus intrahepatic covalently closed circular DNA levels.

Authors:  Danny Ka-Ho Wong; Man-Fung Yuen; Vincent Wing-Shun Ngai; James Fung; Ching-Lung Lai
Journal:  Antivir Ther       Date:  2006

7.  Active hepatitis B virus replication in the presence of anti-HBe is associated with viral variants containing an inactive pre-C region.

Authors:  S P Tong; J S Li; L Vitvitski; C Trépo
Journal:  Virology       Date:  1990-06       Impact factor: 3.616

8.  Point mutations in the S and pre-S2 genes observed in two hepatitis B virus carriers positive for antibody to hepatitis B surface antigen.

Authors:  T Shinji; N Koide; T Hanafusa; H Hada; T Oka; N Takayama; H Shiraha; M Nakamura; K Ujike; Y Yumoto; T Tsuji
Journal:  Hepatogastroenterology       Date:  1998 Mar-Apr

9.  Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen.

Authors:  K Yamamoto; M Horikita; F Tsuda; K Itoh; Y Akahane; S Yotsumoto; H Okamoto; Y Miyakawa; M Mayumi
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

10.  Molecular analysis of hepatitis B virus "a" determinant in asymptomatic and symptomatic Mexican carriers.

Authors:  Martha-Eugenia Ruiz-Tachiquín; Hilda-Alicia Valdez-Salazar; Vicencio Juárez-Barreto; Margarita Dehesa-Violante; Javier Torres; Onofre Muñoz-Hernández; Ma-Teresa Alvarez-Muñoz
Journal:  Virol J       Date:  2007-01-11       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.